Our study constructed a prognostic risk signature based on genes and suggested a role of the PI3K-Akt signaling pathway and the IL-17 signaling pathways in poor survival of HNSCC, which emphasized the critical importance of pyroptosis in HNSCC and provides a novel perspective of the HNSCC therapy. The gene discussed is AKT1; the disease is head and neck squamous cell carcinoma.